Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1987;10:181-188

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kopecky, R. T.
Right arrow Articles by McAfee, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kopecky, R. T.
Right arrow Articles by McAfee, J. G.

Hypertension, Vol 10, 181-188, Copyright © 1987 by American Heart Association


ARTICLES

Furosemide augments the effects of captopril on nuclear studies in renovascular stenosis

RT Kopecky, FD Thomas and JG McAfee

Captopril facilitates detection of unilateral renovascular hypertension by selectively reducing glomerular filtration rate in affected kidneys. To determine if volume depletion augments this response, we compared the effects of captopril, furosemide, and combined furosemide plus captopril on individual kidney computer-derived clearances of 99mTc- diethylenetriamine pentaacetic acid (DTPA) and [131I]o-iodohippurate in two-kidney, one clip Goldblatt hypertensive rats and normal controls. In clipped kidneys, captopril reduced DTPA clearance significantly from baseline (from 0.31 +/- 0.02 to 0.19 +/- 0.04 ml/min/100 g; p less than 0.02) whereas furosemide alone had no effect (0.28 +/- 0.03 ml/min/100 g). Combined furosemide plus captopril further reduced clipped kidney DTPA clearance to a level significantly less than captopril alone (0.10 +/- 0.02 ml/min/100 g; p less than 0.02). Clipped kidney o- iodohippurate clearance was not changed from baseline by any treatment. In contralateral unclipped and normal kidneys, DTPA clearance did not decline from baseline following either captopril or furosemide plus captopril treatment. Since the dose of captopril used (3 mg/kg by intraperitoneal injection) did not reduce systolic blood pressure of hypertensive rats significantly, these changes probably reflect intrarenal rather than systemic hemodynamic effects of converting enzyme inhibition and are consistent with the hypothesis that captopril interferes with glomerular filtration in stenotic kidneys by reducing efferent arteriolar vascular resistance. Prior volume depletion accentuates the effect of captopril on stenotic kidney glomerular filtration rate, providing improved functional discrimination of stenotic kidneys from contralateral unclipped and normal kidneys. These results indicate that furosemide-induced volume depletion may increase the diagnostic sensitivity of captopril-enhanced 99mTc-DTPA renography in the detection of unilateral renovascular hypertension.


This article has been cited by other articles:


Home page
Arch Intern MedHome page
W. J. Elliott, W. B. Martin, and M. B. Murphy
Comparison of Two Noninvasive Screening Tests for Renovascular Hypertension
Arch Intern Med, March 22, 1993; 153(6): 755 - 764.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
C. T. Postma, A. H. A. M. van Oijen, J. O. Barentsz, T. de Boo, W. H. L. Hoefnagels, F. H. M. Corstens, and T. Thien
The Value of Tests Predicting Renovascular Hypertension in Patients With Renal Artery Stenosis Treated by Angioplasty
Arch Intern Med, August 1, 1991; 151(8): 1531 - 1535.
[Abstract] [PDF]